RELATED CONTENT
NEWS
- ViiV's licensing talks with Medicines Patent Pool progressing towards a deal
- Commitment fee for Glenmark under new crofelemer supply pact with Salix
- US FDA approves flu vaccine formulations for 2011-12 season; firms start shipping
- AstraZeneca heartened by US FDA nod to antiplatelet medicine Brilinta

